Message for Participants enrolled in an ISABELA study and their caregivers in relation to COVID-19 Read more...
Safety of study participants is a priority. At this time, the ISABELA studies are continuing to operate, although within national/state restrictions associated with safety of the study participants and national public safety.
Galapagos is working hard to ensure that all sites across the world are supported during these difficult times and support continuation of study participants in the ISABELA studies.
Supportive guidance is being provided to study sites to cover all aspects of the study such as study visits, blood tests, safety assessments, study medication.
If you have any concerns regarding the study, please contact your study site and raise any questions directly with them.
Please see your Informed Consent Form for assessments and contact details.
Program badań klinicznych ISABELA będzie prowadzony w ponad 200 ośrodkach badawczych. Aktywne ośrodki badawcze są widoczne w obrębie lokalizatora ośrodków badawczych. Jeśli w danym momencie w Twoim rejonie nie są widoczne żadne aktywne ośrodki, prosimy sprawdzić mapę lokalizatora w późniejszym czasie.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.